Arsenic trioxide rewires mantle cell lymphoma response to bortezomib

Although most of the mantle cell lymphoma (MCL) patients initially responded well to bortezomib (BTZ), the dose-dependent toxicities have greatly limited the application of BTZ to MCL. To investigate the efficacy and mechanism of arsenic trioxide (ATO) with BTZ in inducing apoptosis of MCL cells, tw...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Med
Egile Nagusiak: Zhao, Ling-Ling, Liu, Yuan-Fang, Peng, Li-Jun, Fei, Ai-Mei, Cui, Wen, Miao, Sheng-Chao, Hermine, Olivier, Gressin, Remy, Khochbin, Saadi, Chen, Sai-Juan, Wang, Jin, Mi, Jian-Qing
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2015
Gaiak:
Cancer Prevention
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674002/
https://ncbi.nlm.nih.gov/pubmed/26310857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.511
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak